Summary:
- The article discusses the regulatory stance on stem cell therapy for autism, emphasizing that it must be strictly confined to registered clinical trials due to a lack of robust clinical evidence regarding efficacy and safety.
- It highlights the importance of patient safety and ethical considerations, cautioning families against unproven "miracle" treatments while advocating for standardized, evidence-based medical research.